# Entravision Communications Corp: financial statements, quarterly

EVC · NYSE · CIK 1109116 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evc.md) · [Financials](/companies/evc/financials.md) · [Filings](/companies/evc/filings.md) · [Insiders](/companies/evc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [77.4](/filings/0000950170-24-123278.md) | [78.3 d](/filings/0001193125-26-093993.md) | [78.2](/filings/0000950170-25-066954.md) | [82.7](/filings/0000950170-25-103037.md) | [97.2](/filings/0001193125-25-264694.md) | [107 d](/filings/0001193125-26-093993.md) | [91.9](/filings/0001193125-26-206399.md) | [101](/filings/0001193125-26-342382.md) | [121](/filings/0001193125-25-264694.md) | [134 d](/filings/0001193125-26-093993.md) | [197](/filings/0001193125-26-206399.md) | [228](/filings/0001193125-26-342382.md) |
| Cost of revenue | $m | [21.4](/filings/0000950170-24-123278.md) | [19.3 d](/filings/0001193125-26-093993.md) | [22.7](/filings/0000950170-25-066954.md) | [24.4](/filings/0000950170-25-103037.md) | [26.8](/filings/0001193125-25-264694.md) | [28.3 d](/filings/0001193125-26-093993.md) | [33.5](/filings/0001193125-26-206399.md) | [38.0](/filings/0001193125-26-342382.md) | [51.0](/filings/0001193125-25-264694.md) | [61.6 d](/filings/0001193125-26-093993.md) | [102](/filings/0001193125-26-206399.md) | [118](/filings/0001193125-26-342382.md) |
| Selling, general and administrative | $m | [11.9](/filings/0000950170-24-123278.md) | [12.4 d](/filings/0001193125-26-093993.md) | [14.3](/filings/0000950170-25-066954.md) | [14.4](/filings/0000950170-25-103037.md) | [17.1](/filings/0001193125-25-264694.md) | [17.1 d](/filings/0001193125-26-093993.md) | [15.5](/filings/0001193125-26-206399.md) | [16.5](/filings/0001193125-26-342382.md) | [19.0](/filings/0001193125-25-264694.md) | [15.8 d](/filings/0001193125-26-093993.md) | [18.1](/filings/0001193125-26-206399.md) | [19.0](/filings/0001193125-26-342382.md) |
| Operating income | $m | [(3.8)](/filings/0000950170-24-123278.md) | [(15.2) d](/filings/0001193125-26-093993.md) | [(7.6)](/filings/0000950170-25-066954.md) | [(3.3)](/filings/0000950170-25-103037.md) | [7.6](/filings/0001193125-25-264694.md) | [(48.6) d](/filings/0001193125-26-093993.md) | [(52.8)](/filings/0001193125-26-206399.md) | [(0.8)](/filings/0001193125-26-342382.md) | [(9.1)](/filings/0001193125-25-264694.md) | [(20.7) d](/filings/0001193125-26-093993.md) | [20.7](/filings/0001193125-26-206399.md) | [30.0](/filings/0001193125-26-342382.md) |
| Interest expense | $m | [4.3](/filings/0000950170-24-123278.md) | [4.4 d](/filings/0001193125-26-093993.md) | [4.4](/filings/0000950170-25-066954.md) | [4.1](/filings/0000950170-25-103037.md) | [4.1](/filings/0001193125-25-264694.md) | [3.8 d](/filings/0001193125-26-093993.md) | [3.7](/filings/0001193125-26-206399.md) | [4.0](/filings/0001193125-26-342382.md) | [3.8](/filings/0001193125-25-264694.md) | [3.6 d](/filings/0001193125-26-093993.md) | [3.3](/filings/0001193125-26-206399.md) | [3.1](/filings/0001193125-26-342382.md) |
| Income tax | $m | [(1.0)](/filings/0000950170-24-123278.md) | [(5.3) d](/filings/0001193125-26-093993.md) | [(4.1)](/filings/0000950170-25-066954.md) | [(10.7)](/filings/0000950170-25-103037.md) | [15.0](/filings/0001193125-25-264694.md) | [3.9 d](/filings/0001193125-26-093993.md) | [(8.1)](/filings/0001193125-26-206399.md) | [(0.8)](/filings/0001193125-26-342382.md) | [(2.8)](/filings/0001193125-25-264694.md) | [(6.3) d](/filings/0001193125-26-093993.md) | [5.4](/filings/0001193125-26-206399.md) | [7.8](/filings/0001193125-26-342382.md) |
| Net income | $m | [2.7](/filings/0000950170-24-123278.md) | [(18.2) d](/filings/0001193125-26-093993.md) | [(48.9)](/filings/0000950170-25-066954.md) | [(31.7)](/filings/0000950170-25-103037.md) | [(12.0)](/filings/0001193125-25-264694.md) | [(56.4) d](/filings/0001193125-26-093993.md) | [(48.0)](/filings/0001193125-26-206399.md) | [(3.3)](/filings/0001193125-26-342382.md) | [(9.7)](/filings/0001193125-25-264694.md) | [(18.2) d](/filings/0001193125-26-093993.md) | [12.4](/filings/0001193125-26-206399.md) | [19.7](/filings/0001193125-26-342382.md) |
| Diluted EPS | $ per share | [0.03](/filings/0000950170-24-123278.md) | not reported | [(0.55)](/filings/0000950170-25-066954.md) | [(0.35)](/filings/0000950170-25-103037.md) | [(0.13)](/filings/0001193125-25-264694.md) | not reported | [(0.53)](/filings/0001193125-26-206399.md) | [(0.04)](/filings/0001193125-26-342382.md) | [(0.11)](/filings/0001193125-25-264694.md) | not reported | [0.13](/filings/0001193125-26-206399.md) | [0.19](/filings/0001193125-26-342382.md) |
| Basic EPS | $ per share | [0.03](/filings/0000950170-24-123278.md) | not reported | [(0.55)](/filings/0000950170-25-066954.md) | [(0.35)](/filings/0000950170-25-103037.md) | [(0.13)](/filings/0001193125-25-264694.md) | not reported | [(0.53)](/filings/0001193125-26-206399.md) | [(0.04)](/filings/0001193125-26-342382.md) | [(0.11)](/filings/0001193125-25-264694.md) | not reported | [0.13](/filings/0001193125-26-206399.md) | [0.21](/filings/0001193125-26-342382.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0000950170-24-123278.md) | [67.4](/filings/0001193125-26-093993.md) | [98.4](/filings/0000950170-25-066954.md) | [85.1](/filings/0000950170-25-103037.md) | [90.3](/filings/0001193125-25-264694.md) | [95.9](/filings/0001193125-26-093993.md) | [73.6](/filings/0001193125-26-206399.md) | [64.5](/filings/0001193125-26-342382.md) | [61.8](/filings/0001193125-25-264694.md) | [59.4](/filings/0001193125-26-342382.md) | [68.2](/filings/0001193125-26-206399.md) | [80.8](/filings/0001193125-26-342382.md) |
| Current assets | $m | [385](/filings/0000950170-23-058238.md) | [386](/filings/0000950170-25-034661.md) | [380](/filings/0000950170-24-052113.md) | [205](/filings/0000950170-24-093955.md) | [195](/filings/0000950170-24-123278.md) | [186](/filings/0001193125-26-093993.md) | [191](/filings/0000950170-25-066954.md) | [178](/filings/0000950170-25-103037.md) | [184](/filings/0001193125-25-264694.md) | [183](/filings/0001193125-26-342382.md) | [230](/filings/0001193125-26-206399.md) | [244](/filings/0001193125-26-342382.md) |
| Total assets | $m | [876](/filings/0000950170-23-058238.md) | [866](/filings/0000950170-25-034661.md) | [805](/filings/0000950170-24-052113.md) | [570](/filings/0000950170-24-093955.md) | [557](/filings/0000950170-24-123278.md) | [487](/filings/0001193125-26-093993.md) | [436](/filings/0000950170-25-066954.md) | [418](/filings/0000950170-25-103037.md) | [415](/filings/0001193125-25-264694.md) | [388](/filings/0001193125-26-342382.md) | [436](/filings/0001193125-26-206399.md) | [451](/filings/0001193125-26-342382.md) |
| Current liabilities | $m | [256](/filings/0000950170-23-058238.md) | [272](/filings/0000950170-25-034661.md) | [274](/filings/0000950170-24-052113.md) | [67.3](/filings/0000950170-24-093955.md) | [72.3](/filings/0000950170-24-123278.md) | [61.6](/filings/0001193125-26-093993.md) | [65.3](/filings/0000950170-25-066954.md) | [71.7](/filings/0000950170-25-103037.md) | [106](/filings/0001193125-25-264694.md) | [121](/filings/0001193125-26-342382.md) | [164](/filings/0001193125-26-206399.md) | [165](/filings/0001193125-26-342382.md) |
| Total liabilities | $m | [590](/filings/0000950170-23-058238.md) | [600](/filings/0000950170-25-034661.md) | [592](/filings/0000950170-24-052113.md) | [349](/filings/0000950170-24-093955.md) | [350](/filings/0000950170-24-123278.md) | [341](/filings/0001193125-26-093993.md) | [340](/filings/0000950170-25-066954.md) | [328](/filings/0000950170-25-103037.md) | [336](/filings/0001193125-25-264694.md) | [332](/filings/0001193125-26-342382.md) | [371](/filings/0001193125-26-206399.md) | [367](/filings/0001193125-26-342382.md) |
| Long-term debt | $m | [201](/filings/0000950170-23-058238.md) | [198](/filings/0000950170-25-034661.md) | [196](/filings/0000950170-24-052113.md) | [187](/filings/0000950170-24-093955.md) | [187](/filings/0000950170-24-123278.md) | [187](/filings/0001193125-26-093993.md) | [185](/filings/0000950170-25-066954.md) | [172](/filings/0000950170-25-103037.md) | [152](/filings/0001193125-25-264694.md) | [147](/filings/0001193125-26-342382.md) | [142](/filings/0001193125-26-206399.md) | [137](/filings/0001193125-26-342382.md) |
| Current portion of debt | $m | [8.6](/filings/0000950170-23-058238.md) | [8.8](/filings/0000950170-25-034661.md) | [3.4](/filings/0000950170-24-052113.md) | not reported | not reported | not reported | [2.5](/filings/0000950170-25-066954.md) | [5.0](/filings/0000950170-25-103037.md) | [20.0](/filings/0001193125-25-264694.md) | [20.0](/filings/0001193125-26-342382.md) | [20.0](/filings/0001193125-26-206399.md) | [20.0](/filings/0001193125-26-342382.md) |
| Shareholders' equity | $m | [239](/filings/0000950170-23-058238.md) | [223](/filings/0001193125-25-264694.md) | [174](/filings/0001193125-25-264694.md) | [220](/filings/0001193125-25-264694.md) | [207](/filings/0001193125-25-264694.md) | [146](/filings/0001193125-26-342382.md) | [95.6](/filings/0001193125-26-342382.md) | [90.0](/filings/0001193125-26-342382.md) | [78.2](/filings/0001193125-25-264694.md) | [55.4](/filings/0001193125-26-342382.md) | [65.0](/filings/0001193125-26-342382.md) | [83.6](/filings/0001193125-26-342382.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.0 d](/filings/0000950170-24-123278.md) | [6.1 d](/filings/0001193125-26-093993.md) | [33.4](/filings/0000950170-25-066954.md) | [17.7 d](/filings/0000950170-25-103037.md) | [10.9 d](/filings/0001193125-25-264694.md) | [12.8 d](/filings/0001193125-26-093993.md) | [(15.2)](/filings/0001193125-26-206399.md) | [7.8 d](/filings/0001193125-26-342382.md) | [8.3 d](/filings/0001193125-25-264694.md) | [9.8 d](/filings/0001193125-26-093993.md) | [21.8](/filings/0001193125-26-206399.md) | [23.8 d](/filings/0001193125-26-342382.md) |
| Capital expenditure | $m | [5.0 d](/filings/0000950170-24-123278.md) | [7.4 d](/filings/0001193125-26-093993.md) | [2.7](/filings/0000950170-25-066954.md) | [2.0 d](/filings/0000950170-25-103037.md) | [1.6 d](/filings/0001193125-25-264694.md) | [2.2 d](/filings/0001193125-26-093993.md) | [2.6](/filings/0001193125-26-206399.md) | [2.2 d](/filings/0001193125-26-342382.md) | [1.2 d](/filings/0001193125-25-264694.md) | [1.1 d](/filings/0001193125-26-093993.md) | [3.6](/filings/0001193125-26-206399.md) | [3.3 d](/filings/0001193125-26-342382.md) |
| Dividends paid | $m | [4.4 d](/filings/0000950170-24-123278.md) | [4.4 d](/filings/0001193125-26-093993.md) | [4.5](/filings/0000950170-25-066954.md) | [4.5 d](/filings/0000950170-25-103037.md) | [4.5 d](/filings/0001193125-25-264694.md) | [4.5 d](/filings/0001193125-26-093993.md) | [4.5](/filings/0001193125-26-206399.md) | [4.5 d](/filings/0001193125-26-342382.md) | [4.5 d](/filings/0001193125-25-264694.md) | [4.6 d](/filings/0001193125-26-093993.md) | [4.6](/filings/0001193125-26-206399.md) | [4.6 d](/filings/0001193125-26-342382.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [87.4](/filings/0000950170-23-058238.md) | [89.8](/filings/0000950170-24-052113.md) | [87.8](/filings/0000950170-24-093955.md) | [88.0](/filings/0000950170-24-123278.md) | [89.5](/filings/0000950170-25-066954.md) | [90.7](/filings/0000950170-25-103037.md) | [90.0](/filings/0001193125-25-264694.md) | [91.0](/filings/0001193125-26-206399.md) | [91.0](/filings/0001193125-26-342382.md) | [91.0](/filings/0001193125-25-264694.md) | [96.4](/filings/0001193125-26-206399.md) | [103](/filings/0001193125-26-342382.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.